Literature DB >> 25156654

Serious complications associated with regadenoson administration for myocardial perfusion imaging: a commentary.

Fadi G Hage1, Ami E Iskandrian.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25156654     DOI： 10.1007/s12350-014-9985-2

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  9 in total

1.  Seizures associated with regadenoson: a case series.

Authors:  Robert Lee Page; Patrice Spurck; Jacquelyn L Bainbridge; Julie Michalek; Robert A Quaife
Journal:  J Nucl Cardiol       Date:  2012-04       Impact factor: 5.952

2.  Regadenoson induced acute ST-segment elevation myocardial infarction and multivessel coronary thrombosis.

Authors:  David H Hsi; Rajeev Marreddy; Mark Moshiyakhov; Ulrich Luft
Journal:  J Nucl Cardiol       Date:  2013-03-05       Impact factor: 5.952

3.  Regadenoson-induced bradycardia and hypotension: possible mechanism and antidote.

Authors:  S R Underwood; K A Latus; E Reyes; K Standbridge; S Walker; K Wechalekar
Journal:  J Nucl Cardiol       Date:  2014-08-23       Impact factor: 5.952

4.  Regadenoson and seizures: a real clinical concern.

Authors:  Vikram Agarwal; E Gordon DePuey
Journal:  J Nucl Cardiol       Date:  2014-08-23       Impact factor: 5.952

5.  Advanced heart block and unresponsiveness after regadenoson administration during myocardial SPECT study.

Authors:  Vikram Agarwal; E Gordon DePuey
Journal:  Int J Cardiol       Date:  2014-07-12       Impact factor: 4.164

6.  Regadenoson for myocardial perfusion imaging: Is it safe?

Authors:  Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2014-06-19       Impact factor: 5.952

7.  Acute myocardial infarction during regadenoson myocardial perfusion imaging.

Authors:  Sachil Shah; David Parra; Robert S Rosenstein
Journal:  Pharmacotherapy       Date:  2013-03-07       Impact factor: 4.705

8.  Asystole following regadenoson infusion in stable outpatients.

Authors:  Jeffrey Rosenblatt; Deirdre Mooney; Timothy Dunn; Mylan Cohen
Journal:  J Nucl Cardiol       Date:  2014-05-31       Impact factor: 5.952

9.  Regadenoson in Europe: first-year experience of regadenoson stress combined with submaximal exercise in patients undergoing myocardial perfusion scintigraphy.

Authors:  M Brinkert; E Reyes; S Walker; K Latus; A Maenhout; R Mizumoto; C Nkomo; K Standbridge; K Wechalekar; S R Underwood
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-22       Impact factor: 9.236
  9 in total
  5 in total

1.  Vasodilator stress agents for myocardial perfusion imaging.

Authors:  Rayan Saab; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2016-02-02       Impact factor: 5.952

2.  Safety of stress testing in patients with elevated cardiac biomarkers: Are all modalities created equal?

Authors:  Rami Doukky; Yasmeen Golzar
Journal:  J Nucl Cardiol       Date:  2016-02-17       Impact factor: 5.952

Review 3.  Review of cardiovascular imaging in The Journal of Nuclear Cardiology in 2014: Part 2 of 2: Myocardial perfusion imaging.

Authors:  Fadi G Hage; Wael A AlJaroudi
Journal:  J Nucl Cardiol       Date:  2015-04-30       Impact factor: 5.952

Review 4.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology in 2017. Part 2 of 2: Myocardial perfusion imaging.

Authors:  Fadi G Hage; Wael A AlJaroudi
Journal:  J Nucl Cardiol       Date:  2018-04-16       Impact factor: 5.952

5.  Serious complications associated with regadenoson administration for myocardial perfusion imaging.

Authors:  Therese Kitt; Jeanette Jiang
Journal:  J Nucl Cardiol       Date:  2014-12-30       Impact factor: 5.952
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.